BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Böhme D, Beck-Sickinger AG. Drug delivery and release systems for targeted tumor therapy. J Pept Sci 2015;21:186-200. [PMID: 25703117 DOI: 10.1002/psc.2753] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu G, Lu D, Zhu S, Hao M, Yang X, Wang X, Zhang Y. A new self-immolative colistin prodrug with dual targeting functionalities and reduced toxicity for the treatment of intracellular bacterial infections. J Biomed Mater Res A 2022;110:1590-8. [PMID: 35593460 DOI: 10.1002/jbm.a.37410] [Reference Citation Analysis]
2 Dohare A, Sudhakar S, Brodbeck B, Mukherjee A, Brecht M, Kandelbauer A, Schäffer E, Mayer HA. Anisotropic and Amphiphilic Mesoporous Core-Shell Silica Microparticles Provide Chemically Selective Environments for Simultaneous Delivery of Curcumin and Quercetin. Langmuir 2021;37:13460-70. [PMID: 34730962 DOI: 10.1021/acs.langmuir.1c02210] [Reference Citation Analysis]
3 Zhou J, Li Y, Huang W, Shi W, Qian H. Source and exploration of the peptides used to construct peptide-drug conjugates. Eur J Med Chem 2021;224:113712. [PMID: 34303870 DOI: 10.1016/j.ejmech.2021.113712] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Liu G, Jiang Z, Lovell JF, Zhang L, Zhang Y. Design of a Thiol-Responsive, Traceless Prodrug with Rapid Self-Immolation for Cancer Chemotherapy. ACS Appl Bio Mater 2021;4:4982-9. [PMID: 35007046 DOI: 10.1021/acsabm.1c00247] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
5 De Pascalis L, Yau MK, Svatunek D, Tan Z, Tekkam S, Houk KN, Finn MG. The Influence of Substitution on Thiol-Induced Oxanorbornadiene Fragmentation. Org Lett 2021;23:3751-4. [PMID: 33851842 DOI: 10.1021/acs.orglett.1c01164] [Reference Citation Analysis]
6 Rana A, Bhatnagar S. Advancements in folate receptor targeting for anti-cancer therapy: A small molecule-drug conjugate approach. Bioorg Chem 2021;112:104946. [PMID: 33989916 DOI: 10.1016/j.bioorg.2021.104946] [Reference Citation Analysis]
7 Sharma A, Sheyi R, de la Torre BG, El-Faham A, Albericio F. s-Triazine: A Privileged Structure for Drug Discovery and Bioconjugation. Molecules 2021;26:864. [PMID: 33562072 DOI: 10.3390/molecules26040864] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
8 Wu TC, Lee PY, Lai CL, Lai CH. Synthesis of Multi-Functional Nano-Vectors for Target-Specific Drug Delivery. Polymers (Basel) 2021;13:451. [PMID: 33573359 DOI: 10.3390/polym13030451] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Anselmi M, Borbély A, Figueras E, Michalek C, Kemker I, Gentilucci L, Sewald N. Linker Hydrophilicity Modulates the Anticancer Activity of RGD-Cryptophycin Conjugates. Chemistry 2021;27:1015-22. [PMID: 32955139 DOI: 10.1002/chem.202003471] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Hawryłkiewicz A, Ptaszyńska N. Gemcitabine Peptide-Based Conjugates and Their Application in Targeted Tumor Therapy. Molecules 2021;26:E364. [PMID: 33445797 DOI: 10.3390/molecules26020364] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
11 Emir Diltemiz S, Tavafoghi M, de Barros NR, Kanada M, Heinämäki J, Contag C, Seidlits SK, Ashammakhi N. Use of artificial cells as drug carriers. Mater Chem Front 2021;5:6672-92. [DOI: 10.1039/d1qm00717c] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Sharma A, Kumar A, El-Faham A, de la Torre BG, Albericio F. Exploiting azido-dichloro-triazine as a linker for regioselective incorporation of peptides through their N, O, S functional groups. Bioorg Chem 2020;104:104334. [PMID: 33142409 DOI: 10.1016/j.bioorg.2020.104334] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Ziffert I, Kaiser A, Hoppenz P, Mörl K, Beck-Sickinger AG. Shuttling of Peptide-Drug Conjugates by G Protein-Coupled Receptors Is Significantly Improved by Pulsed Application. ChemMedChem 2021;16:164-78. [PMID: 32700391 DOI: 10.1002/cmdc.202000490] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
14 Li M, Zhao G, Su WK, Shuai Q. Enzyme-Responsive Nanoparticles for Anti-tumor Drug Delivery. Front Chem 2020;8:647. [PMID: 32850662 DOI: 10.3389/fchem.2020.00647] [Cited by in Crossref: 7] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
15 Sedlacek O, Van Driessche A, Uvyn A, De Geest BG, Hoogenboom R. Poly(2-methyl-2-oxazoline) conjugates with doxorubicin: From synthesis of high drug loading water-soluble constructs to in vitro anti-cancer properties. J Control Release 2020;326:53-62. [PMID: 32565042 DOI: 10.1016/j.jconrel.2020.06.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Obayemi JD, Salifu AA, Eluu SC, Uzonwanne VO, Jusu SM, Nwazojie CC, Onyekanne CE, Ojelabi O, Payne L, Moore CM, King JA, Soboyejo WO. LHRH-Conjugated Drugs as Targeted Therapeutic Agents for the Specific Targeting and Localized Treatment of Triple Negative Breast Cancer. Sci Rep 2020;10:8212. [PMID: 32427904 DOI: 10.1038/s41598-020-64979-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
17 Worm DJ, Els‐heindl S, Beck‐sickinger AG. Targeting of peptide‐binding receptors on cancer cells with peptide‐drug conjugates. Peptide Science 2020;112. [DOI: 10.1002/pep2.24171] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
18 Conibear AC, Schmid A, Kamalov M, Becker CFW, Bello C. Recent Advances in Peptide-Based Approaches for Cancer Treatment. Curr Med Chem 2020;27:1174-205. [PMID: 29173146 DOI: 10.2174/0929867325666171123204851] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
19 Pethő L, Kasza G, Lajkó E, Láng O, Kőhidai L, Iván B, Mező G. Amphiphilic drug–peptide–polymer conjugates based on poly(ethylene glycol) and hyperbranched polyglycerol for epidermal growth factor receptor targeting: the effect of conjugate aggregation on in vitro activity. Soft Matter 2020;16:5759-69. [DOI: 10.1039/d0sm00428f] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
20 Hoppenz P, Els-Heindl S, Kellert M, Kuhnert R, Saretz S, Lerchen HG, Köbberling J, Riedl B, Hey-Hawkins E, Beck-Sickinger AG. A Selective Carborane-Functionalized Gastrin-Releasing Peptide Receptor Agonist as Boron Delivery Agent for Boron Neutron Capture Therapy. J Org Chem 2020;85:1446-57. [PMID: 31813224 DOI: 10.1021/acs.joc.9b02406] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
21 Wittrisch S, Klöting N, Mörl K, Chakaroun R, Blüher M, Beck-Sickinger AG. NPY1R-targeted peptide-mediated delivery of a dual PPARα/γ agonist to adipocytes enhances adipogenesis and prevents diabetes progression. Mol Metab 2020;31:163-80. [PMID: 31918918 DOI: 10.1016/j.molmet.2019.11.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
22 Li S, Zhao H, Mao X, Fan Y, Liang X, Wang R, Xiao L, Wang J, Liu Q, Zhao G. Transferrin Receptor Targeted Cellular Delivery of Doxorubicin Via a Reduction-Responsive Peptide-Drug Conjugate. Pharm Res 2019;36. [DOI: 10.1007/s11095-019-2688-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
23 Baumann AL, Hackenberger CPR. Tag and release: strategies for the intracellular cleavage of protein conjugates. Current Opinion in Chemical Biology 2019;52:39-46. [DOI: 10.1016/j.cbpa.2019.04.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
24 Sharma A, Sheyi R, Kumar A, El-Faham A, de la Torre BG, Albericio F. Investigating Triorthogonal Chemoselectivity. Effect of Azide Substitution on the Triazine Core. Org Lett 2019;21:7888-92. [PMID: 31532213 DOI: 10.1021/acs.orglett.9b02878] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
25 Yang V, Pedrosa SS, Fernandes R, Maurício AC, Koksch B, Gärtner F, Amorim I, Vale N. Synthesis of PEGylated methotrexate conjugated with a novel CPP6, in sillico structural insights and activity in MCF-7 cells. Journal of Molecular Structure 2019;1192:201-7. [DOI: 10.1016/j.molstruc.2019.04.118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
26 E M Eid E, S Alanazi A, Koosha S, A Alrasheedy A, Azam F, M Taban I, Khalilullah H, Sadiq Al-Qubaisi M, A Alshawsh M. Zerumbone Induces Apoptosis in Breast Cancer Cells by Targeting αvβ3 Integrin upon Co-Administration with TP5-iRGD Peptide. Molecules 2019;24:E2554. [PMID: 31337024 DOI: 10.3390/molecules24142554] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
27 Jafari B, Pourseif MM, Barar J, Rafi MA, Omidi Y. Peptide-mediated drug delivery across the blood-brain barrier for targeting brain tumors. Expert Opinion on Drug Delivery 2019;16:583-605. [DOI: 10.1080/17425247.2019.1614911] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
28 Figueras E, Martins A, Borbély A, Le Joncour V, Cordella P, Perego R, Modena D, Pagani P, Esposito S, Auciello G, Frese M, Gallinari P, Laakkonen P, Steinkühler C, Sewald N. Octreotide Conjugates for Tumor Targeting and Imaging. Pharmaceutics 2019;11:E220. [PMID: 31067748 DOI: 10.3390/pharmaceutics11050220] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
29 Klahn P, Fetz V, Ritter A, Collisi W, Hinkelmann B, Arnold T, Tegge W, Rox K, Hüttel S, Mohr KI, Wink J, Stadler M, Wissing J, Jänsch L, Brönstrup M. The nuclear export inhibitor aminoratjadone is a potent effector in extracellular-targeted drug conjugates. Chem Sci 2019;10:5197-210. [PMID: 31191875 DOI: 10.1039/c8sc05542d] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
30 Pagel M. Inverse electron demand Diels-Alder (IEDDA) reactions in peptide chemistry. J Pept Sci 2019;25:e3141. [PMID: 30585397 DOI: 10.1002/psc.3141] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
31 Sharma A, El-Faham A, de la Torre BG, Albericio F. Exploring the Orthogonal Chemoselectivity of 2,4,6-Trichloro-1,3,5-Triazine (TCT) as a Trifunctional Linker With Different Nucleophiles: Rules of the Game. Front Chem 2018;6:516. [PMID: 30443543 DOI: 10.3389/fchem.2018.00516] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
32 Lajkó E, Spring S, Hegedüs R, Biri-Kovács B, Ingebrandt S, Mező G, Kőhidai L. Comparative cell biological study of in vitro antitumor and antimetastatic activity on melanoma cells of GnRH-III-containing conjugates modified with short-chain fatty acids. Beilstein J Org Chem 2018;14:2495-509. [PMID: 30344773 DOI: 10.3762/bjoc.14.226] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
33 Hofmann S, Lindner J, Beck-sickinger AG, Hey-hawkins E, Bellmann-sickert K. Carbaboranylation of Truncated C-Terminal Neuropeptide Y Analogue Leads to Full hY 1 Receptor Agonism. ChemBioChem 2018;19:2300-6. [DOI: 10.1002/cbic.201800343] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
34 Rong L, Qin S, Zhang C, Cheng Y, Feng J, Wang S, Zhang X. Biomedical applications of functional peptides in nano-systems. Materials Today Chemistry 2018;9:91-102. [DOI: 10.1016/j.mtchem.2018.06.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 4.8] [Reference Citation Analysis]
35 Tashima T. Effective cancer therapy based on selective drug delivery into cells across their membrane using receptor-mediated endocytosis. Bioorg Med Chem Lett 2018;28:3015-24. [PMID: 30031619 DOI: 10.1016/j.bmcl.2018.07.012] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
36 Savoie H, Figliola C, Marchal E, Crabbe BW, Hallett-Tapley GL, Boyle RW, Thompson A. Photo-induced anticancer activity and singlet oxygen production of prodigiosenes. Photochem Photobiol Sci 2018;17:599-606. [PMID: 29648558 DOI: 10.1039/c8pp00060c] [Reference Citation Analysis]
37 Marchal E, Figliola C, Thompson A. Prodigiosenes conjugated to tamoxifen and estradiol. Org Biomol Chem 2017;15:5410-27. [PMID: 28628182 DOI: 10.1039/c7ob00943g] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Muguruma K, Shirasaka T, Akiyama D, Fukumoto K, Taguchi A, Takayama K, Taniguchi A, Hayashi Y. An Efficient Method for the Conjugation of Hydrophilic and Hydrophobic Components by Solid-Phase-Assisted Disulfide Ligation. Angew Chem Int Ed 2018;57:2170-3. [DOI: 10.1002/anie.201712324] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
39 Muguruma K, Shirasaka T, Akiyama D, Fukumoto K, Taguchi A, Takayama K, Taniguchi A, Hayashi Y. An Efficient Method for the Conjugation of Hydrophilic and Hydrophobic Components by Solid-Phase-Assisted Disulfide Ligation. Angew Chem 2018;130:2192-5. [DOI: 10.1002/ange.201712324] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Zhang Z, Sheng J, Zhang M, Ma X, Geng Z, Wang Z. Dual-modal imaging and excellent anticancer efficiency of cisplatin and doxorubicin loaded NaGdF 4 :Yb 3+ /Er 3+ nanoparticles. RSC Adv 2018;8:22216-25. [DOI: 10.1039/c8ra03898h] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
41 Liu L, Zhang C, Li Z, Wang C, Bi J, Yin S, Wang Q, Yu R, Liu Y, Su Z. Albumin Binding Domain Fusing R/K-X-X-R/K Sequence for Enhancing Tumor Delivery of Doxorubicin. Mol Pharm 2017;14:3739-49. [PMID: 28950700 DOI: 10.1021/acs.molpharmaceut.7b00497] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
42 Serra M, Peviani EG, Bernardi E, Colombo L. Synthesis of Variously Functionalized Azabicycloalkane Scaffolds by Domino Metathesis Reactions. J Org Chem 2017;82:11091-101. [PMID: 28953382 DOI: 10.1021/acs.joc.7b02047] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
43 Srinivasarao M, Low PS. Ligand-Targeted Drug Delivery. Chem Rev 2017;117:12133-64. [DOI: 10.1021/acs.chemrev.7b00013] [Cited by in Crossref: 218] [Cited by in F6Publishing: 186] [Article Influence: 43.6] [Reference Citation Analysis]
44 Lelle M, Freidel C, Kaloyanova S, Müllen K, Peneva K. Multivalency: Key Feature in Overcoming Drug Resistance with a Cleavable Cell-Penetrating Peptide-Doxorubicin Conjugate. Int J Pept Res Ther 2018;24:355-67. [DOI: 10.1007/s10989-017-9622-4] [Reference Citation Analysis]
45 Conibear AC, Hager S, Mayr J, Klose MHM, Keppler BK, Kowol CR, Heffeter P, Becker CFW. Multifunctional αvβ6 Integrin-Specific Peptide-Pt(IV) Conjugates for Cancer Cell Targeting. Bioconjug Chem 2017;28:2429-39. [PMID: 28796473 DOI: 10.1021/acs.bioconjchem.7b00421] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
46 Mousavizadeh A, Jabbari A, Akrami M, Bardania H. Cell targeting peptides as smart ligands for targeting of therapeutic or diagnostic agents: a systematic review. Colloids Surf B Biointerfaces 2017;158:507-17. [PMID: 28738290 DOI: 10.1016/j.colsurfb.2017.07.012] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 6.4] [Reference Citation Analysis]
47 Weiss C, Figueras E, Borbely AN, Sewald N. Cryptophycins: cytotoxic cyclodepsipeptides with potential for tumor targeting. J Pept Sci 2017;23:514-31. [PMID: 28661555 DOI: 10.1002/psc.3015] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
48 Vats K, Satpati D, Sharma R, Kumar C, Sarma HD, Dash A. 99m Tc-labeled NGR-chlorambucil conjugate, 99m Tc-HYNIC-CLB-c(NGR) for targeted chemotherapy and molecular imaging. J Label Compd Radiopharm 2017;60:431-8. [DOI: 10.1002/jlcr.3522] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
49 Khan M, Huang T, Lin CY, Wu J, Fan BM, Bian ZX. Exploiting cancer's phenotypic guise against itself: targeting ectopically expressed peptide G-protein coupled receptors for lung cancer therapy. Oncotarget 2017;8:104615-37. [PMID: 29262666 DOI: 10.18632/oncotarget.18403] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
50 Ljubimova JY, Sun T, Mashouf L, Ljubimov AV, Israel LL, Ljubimov VA, Falahatian V, Holler E. Covalent nano delivery systems for selective imaging and treatment of brain tumors. Adv Drug Deliv Rev 2017;113:177-200. [PMID: 28606739 DOI: 10.1016/j.addr.2017.06.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 9.6] [Reference Citation Analysis]
51 Dissanayake S, Denny WA, Gamage S, Sarojini V. Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides. Journal of Controlled Release 2017;250:62-76. [DOI: 10.1016/j.jconrel.2017.02.006] [Cited by in Crossref: 139] [Cited by in F6Publishing: 151] [Article Influence: 27.8] [Reference Citation Analysis]
52 Mion G, Mari C, Da ros T, Rubbiani R, Gasser G, Gianferrara T. Towards the Synthesis of New Tumor Targeting Photosensitizers for Photodynamic Therapy and Imaging Applications. ChemistrySelect 2017;2:190-200. [DOI: 10.1002/slct.201601960] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
53 Pramanik AK, Siddikuzzaman, Palanimuthu D, Somasundaram K, Samuelson AG. Biotin Decorated Gold Nanoparticles for Targeted Delivery of a Smart-Linked Anticancer Active Copper Complex: In Vitro and In Vivo Studies. Bioconjug Chem 2016;27:2874-85. [PMID: 27998075 DOI: 10.1021/acs.bioconjchem.6b00537] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
54 Galli S, Naranjo A, Van Ryn C, Tilan JU, Trinh E, Yang C, Tsuei J, Hong SH, Wang H, Izycka-Swieszewska E, Lee YC, Rodriguez OC, Albanese C, Kitlinska J. Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma. Am J Pathol 2016;186:3040-53. [PMID: 27743558 DOI: 10.1016/j.ajpath.2016.07.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
55 Hanna RD, Naro Y, Deiters A, Floreancig PE. Alcohol, Aldehyde, and Ketone Liberation and Intracellular Cargo Release through Peroxide-Mediated α-Boryl Ether Fragmentation. J Am Chem Soc 2016;138:13353-60. [PMID: 27636404 DOI: 10.1021/jacs.6b07890] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
56 Zhu S, Wang Q, Jiang J, Luo Y, Sun Z. A conjugate of methotrexate and an analog of luteinizing hormone releasing hormone shows increased efficacy against prostate cancer. Sci Rep 2016;6:33894. [PMID: 27654169 DOI: 10.1038/srep33894] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
57 Agarwalla P, Banerjee R. N-end rule pathway inhibition assists colon tumor regression via necroptosis. Mol Ther Oncolytics 2016;3:16020. [PMID: 27556106 DOI: 10.1038/mto.2016.20] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
58 Wakabayashi N, Yano Y, Kawano K, Matsuzaki K. A pH-dependent charge reversal peptide for cancer targeting. Eur Biophys J 2017;46:121-7. [PMID: 27278924 DOI: 10.1007/s00249-016-1145-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
59 Stejskalová A, Kiani MT, Almquist BD. Programmable biomaterials for dynamic and responsive drug delivery. Exp Biol Med (Maywood) 2016;241:1127-37. [PMID: 27190245 DOI: 10.1177/1535370216649445] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
60 Böhme D, Krieghoff J, Beck-sickinger AG. Double Methotrexate-Modified Neuropeptide Y Analogues Express Increased Toxicity and Overcome Drug Resistance in Breast Cancer Cells. J Med Chem 2016;59:3409-17. [DOI: 10.1021/acs.jmedchem.6b00043] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
61 Gunnoo SB, Madder A. Bioconjugation – using selective chemistry to enhance the properties of proteins and peptides as therapeutics and carriers. Org Biomol Chem 2016;14:8002-13. [DOI: 10.1039/c6ob00808a] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 7.3] [Reference Citation Analysis]
62 Lai W, Shum HC. A stimuli-responsive nanoparticulate system using poly(ethylenimine)-graft-polysorbate for controlled protein release. Nanoscale 2016;8:517-28. [DOI: 10.1039/c5nr06641g] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 7.2] [Reference Citation Analysis]
63 Pagel M, Meier R, Braun K, Wiessler M, Beck-sickinger AG. On-resin Diels–Alder reaction with inverse electron demand: an efficient ligation method for complex peptides with a varying spacer to optimize cell adhesion. Org Biomol Chem 2016;14:4809-16. [DOI: 10.1039/c6ob00314a] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
64 Taghdisi SM, Danesh NM, Ramezani M, Abnous K. Targeted delivery of vincristine to T-cell acute lymphoblastic leukemia cells using an aptamer-modified albumin conjugate. RSC Adv 2016;6:46366-71. [DOI: 10.1039/c6ra08481h] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
65 Tilan J, Kitlinska J. Neuropeptide Y (NPY) in tumor growth and progression: Lessons learned from pediatric oncology. Neuropeptides 2016;55:55-66. [PMID: 26549645 DOI: 10.1016/j.npep.2015.10.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
66 Li J, Tian Y, Wu A. Neuropeptide Y receptors: a promising target for cancer imaging and therapy. Regen Biomater 2015;2:215-9. [PMID: 26816643 DOI: 10.1093/rb/rbv013] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 4.9] [Reference Citation Analysis]
67 Merten H, Brandl F, Plückthun A, Zangemeister-Wittke U. Antibody-Drug Conjugates for Tumor Targeting-Novel Conjugation Chemistries and the Promise of non-IgG Binding Proteins. Bioconjug Chem 2015;26:2176-85. [PMID: 26086208 DOI: 10.1021/acs.bioconjchem.5b00260] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]